Allergy Therapeutics (AGY) — Working Capital to Net Assets Ratio
Allergy Therapeutics (AGY) has a Working Capital to Net Assets ratio of -26.5% as of June 2025. Working capital of GBX7.49 Million (current assets of GBX34.68 Million minus current liabilities of GBX27.19 Million) is measured against net assets of GBX-28.19 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AGY net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Allergy Therapeutics Working Capital to Net Assets (2002–2025)
This chart shows how Allergy Therapeutics's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2025, the ratio stands at -26.5%, reflecting working capital of GBX7.49 Million against net assets of GBX-28.19 Million GBX. Check AGY goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Allergy Therapeutics (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Allergy Therapeutics from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Allergy Therapeutics (AGY) total market value.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -26.5% | GBX7.49 Million | GBX-28.19 Million | GBX34.68 Million | GBX27.19 Million | ▼ -375.3 pp |
| 2024 | 348.8% | GBX12.94 Million | GBX3.71 Million | GBX33.48 Million | GBX20.55 Million | ▼ -375.4 pp |
| 2023 | 724.2% | GBX14.96 Million | GBX2.07 Million | GBX33.53 Million | GBX18.57 Million | ▲ +659.7 pp |
| 2022 | 64.5% | GBX24.34 Million | GBX37.77 Million | GBX42.39 Million | GBX18.05 Million | ▼ -17.2 pp |
| 2021 | 81.6% | GBX39.63 Million | GBX48.53 Million | GBX57.86 Million | GBX18.23 Million | ▼ -2.7 pp |
| 2020 | 84.4% | GBX36.94 Million | GBX43.78 Million | GBX55.17 Million | GBX18.23 Million | ▲ +5.1 pp |
| 2019 | 79.3% | GBX29.77 Million | GBX37.56 Million | GBX46.62 Million | GBX16.86 Million | ▲ +8.5 pp |
| 2018 | 70.8% | GBX16.30 Million | GBX23.03 Million | GBX30.93 Million | GBX14.63 Million | ▼ -7.5 pp |
| 2017 | 78.2% | GBX23.44 Million | GBX29.96 Million | GBX37.46 Million | GBX14.02 Million | ▼ -4.5 pp |
| 2016 | 82.7% | GBX25.09 Million | GBX30.32 Million | GBX37.61 Million | GBX12.52 Million | ▲ +6.2 pp |
| 2015 | 76.5% | GBX26.37 Million | GBX34.47 Million | GBX33.79 Million | GBX7.42 Million | ▲ +25.2 pp |
| 2014 | 51.3% | GBX7.74 Million | GBX15.07 Million | GBX14.21 Million | GBX6.47 Million | ▲ +4.7 pp |
| 2013 | 46.6% | GBX6.84 Million | GBX14.67 Million | GBX14.46 Million | GBX7.62 Million | ▲ +10.4 pp |
| 2012 | 36.2% | GBX5.29 Million | GBX14.59 Million | GBX13.03 Million | GBX7.75 Million | ▼ -139.9 pp |
| 2011 | 176.1% | GBX3.77 Million | GBX2.14 Million | GBX14.91 Million | GBX11.15 Million | ▲ +52.1 pp |
| 2010 | 124.0% | GBX4.82 Million | GBX3.89 Million | GBX14.80 Million | GBX9.98 Million | ▲ +70.8 pp |
| 2009 | 53.2% | GBX-12.33 Million | GBX-23.18 Million | GBX9.44 Million | GBX21.77 Million | ▲ +81.7 pp |
| 2008 | -28.4% | GBX3.21 Million | GBX-11.29 Million | GBX11.32 Million | GBX8.11 Million | ▼ -65.4 pp |
| 2007 | 37.0% | GBX3.18 Million | GBX8.60 Million | GBX14.04 Million | GBX10.86 Million | ▼ -43.0 pp |
| 2006 | 80.0% | GBX26.15 Million | GBX32.70 Million | GBX31.09 Million | GBX4.94 Million | ▲ +6.0 pp |
| 2005 | 74.0% | GBX14.86 Million | GBX20.08 Million | GBX20.98 Million | GBX6.12 Million | ▲ +41.6 pp |
| 2004 | 32.4% | GBX2.29 Million | GBX7.08 Million | GBX5.57 Million | GBX3.28 Million | ▲ +5.3 pp |
| 2003 | 27.0% | GBX1.50 Million | GBX5.55 Million | GBX5.50 Million | GBX4.00 Million | ▲ +3.9 pp |
| 2002 | 23.1% | GBX-1.02 Million | GBX-4.40 Million | GBX3.58 Million | GBX4.59 Million | — |